Discovery Of Potential New Eye Tumor Treatment
8/08/2011

New research from a team including several Carnegie scientists demonstrates that a specific small segment of RNA could play a key role in the growth of a type of malignant childhood eye tumor called retinoblastoma. The tumor is associated with mutations of a protein called Rb, or retinoblastoma protein...

More Successful Transplants Following Out Of Body Experience For Stem Cells
8/07/2011

New research finds that growing blood stem cells in the laboratory for about a week may help to overcome one of the most difficult roadblocks to successful transplantation, immune rejection. The study, published by Cell Press in the August issue of the journal Cell Stem Cell, may lead to more promising therapeutic strategies for transplanting blood stem cells...

President Hugo Chavez Returning To Cuba For More Cancer Treatment
8/06/2011

President of Venezuela, Hugo Chavez, has announced that he is returning to Cuba for further chemotherapy treatment. In June he had a tumor surgically removed from his pelvic region, and received a bout of chemotherapy last month. Surprisingly, he has managed to get away without being specific about exactly what type of cancer he has...

Why Some Patients Do Not Respond To Standard Lymphoma Therapy Discovered
8/06/2011

University of Southampton (England) researchers uncovered clues as to why several patients do not react to the standard drug for the blood cancer lymphoma, increasing optimism that additional effective treatments can be designed...

QIAGEN Completes Second U.S.Submission For Companion Diagnostic To Guide Treatment Decisions In Colorectal Cancer
8/06/2011

Frankfurt, Prime Standard: QIA) announced it has completed its second U.S. submission of the therascreen® KRAS RGQ PCR Kit for use as a companion diagnostic paired with Erbitux® (cetuximab), a leading drug for treatment of patients with metastatic colorectal cancer (mCRC). Erbitux is marketed in the United States by Bristol-Myers Squibb Company and Eli Lilly and Company...

Unresectable Colon Cancer Fuels US Markets For Colonic, Pyloric And Prostatic Stents
8/06/2011

Global Information, Inc. presents a new market research report, "US Markets for Nonvascular Stents 2011" by Millennium Research Group. A key driver of the growth in colonic and duodenal/pyloric stents will be in the treatment of unresectable colon cancer, which is increasing in incidence and cannot be treated with surgery...

South Florida Radiation Oncology On The Forefront Of Cancer Treatment With The TrueBeam™ Radiotherapy System From Varian Medical Systems
8/06/2011

In a promising development for cancer patients in The Palm Beach area, South Florida Radiation Oncology announced today that it has acquired the TrueBeam system, an innovative system that enables a radically different approach to treating cancer with image-guided radiotherapy...

Dietary-Intervention Study For Prostate Cancer Accruing Patients
8/06/2011

Two researchers from Roswell Park Cancer Institute (RPCI) have opened a clinical trial that will assess the impact of dietary change to control prostate cancer...

Sentinel Node Biopsy Safe, Effective In Head And Neck Melanomas, U-M Study Finds
8/06/2011

A common technique for determining whether melanoma has spread can be used safely and effectively even in tumors from the head and neck area, according to a new study from the University of Michigan Comprehensive Cancer Center. Sentinel lymph node biopsy involves injecting a special dye to identify the first node where cancer would likely spread...

Risk Of Heart Failure From Chemotherapy Reduced By Hormone
8/06/2011

Recent studies have shown that the heart contains cardiac stem cells that can contribute to regeneration and healing during disease and aging. However, little is known about the molecules and pathways that regulate these cells. Now, a new study utilizing a heart failure model is providing insight into one way to coax the cardiac stem cells into repairing the damaged heart...